If you’ve bought a cough syrup or health tonic off the shelf before, that’s about to change for certain products. Here’s what’s happening.
What exactly changed?
The Ministry of Health and Family Welfare has notified the Drugs (Tenth Amendment) Rules, 2026, bringing oral formulations containing more than 12% alcohol by volume in bottles or packs exceeding 30 ml under the stricter Schedule H1 category of the Drugs Rules, 1945. In simple terms: oral medicines with more than 12% alcohol, sold in bottles bigger than 30 ml, will now need a doctor’s prescription to buy.
Why does this matter and what was the old rule?
Previously, many of these products were exempt from strict licensing under a provision called Schedule K, which allowed formulations like tinctures of cardamom, ginger, and other aromatic preparations to be sold without needing a special license — even though some of these contained ethyl alcohol at concentrations as high as 80–90% by volume. That loophole made such products an easy target for misuse.
What products are affected?
The change applies mainly to cough syrups, medicinal tonics, and oral liquid formulations that contain more than 12% ethyl alcohol and are sold in bottles larger than 30 ml. Smaller pack sizes aren’t covered by the tightest rules. The 30 ml packaging threshold specifically exempts smaller, single-dose packs from the toughest documentation requirements, with the tighter rules aimed at larger containers more likely to be diverted for non-medical use.
What will actually change at the pharmacy counter?
Once a product falls under Schedule H1, three things follow:
- You’ll need a valid prescription. Schedule H1 medicines can only be sold on the prescription of a registered medical practitioner.
- Pharmacies must keep detailed records. Pharmacists are required to maintain a separate register recording details such as the patient’s name, the prescribing doctor’s particulars, and the quantity supplied, with records preserved for a prescribed period — at least three years.
- Manufacturers and sellers need proper licenses. Since these products no longer qualify for the Schedule K exemption, manufacturers and sellers will now need to obtain proper licenses under the Drugs and Cosmetics Act, 1940, just like other regulated medicines.
Why is the government doing this?
The core concern is misuse. The government said it had received specific concerns from state governments about these high-alcohol formulations being misused, and framed the change as part of a broader push to strengthen India’s drug regulatory framework and promote more rational, responsible use of medicines. Separately, cough syrups have also been a concern for a different reason — reports have surfaced of large-scale smuggling of codeine-based cough syrups across various states, and alcohol-containing medicines being frequently misused for intoxication, adding to the case for tighter controls.
When does this take effect?
This isn’t immediate. The rule was notified on July 8, 2026, following draft rules that were published on October 16, 2025 for public consultation, with no objections received during that period. Importantly, the amendment will come into force six months after its publication in the Official Gazette — so there’s a transition window before pharmacies must fully comply.
What should patients do?
- If you regularly use a high-alcohol tonic or cough syrup for a genuine medical condition, talk to your doctor now so you have a valid prescription in hand before the rule kicks in.
- Don’t panic, this is not a blanket ban. It doesn’t stop these medicines from being sold; it just means larger bottles will need a prescription and proper paperwork.
- Expect more questions and documentation at the pharmacy counter once the rule takes effect — this is a safety measure, not a barrier to your treatment.
Sources:
- Medical Dialogues: “Oral Medicines with Over 12% Alcohol to Face Stricter Prescription Norms Under Schedule H1: Health Ministry”
- BizzBuzz: “Cough Syrups, Health Tonics With Over 12% Alcohol to Need Prescription”
- Lapaas Voice:”India Bans Over-the-Counter Sale of Medicines Containing Over 12% Alcohol”
- ByNewsIndia:”Medicines containing more than 12% alcohol will not be available without a doctor’s prescription”